WuXi Biologics and Inhibrx Enter an Exclusive Partnership for GMP Manufacturing
I-Mab Biopharma Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Three Bispecific Antibody Programs
WuXi Biologics and Immune Pharmaceuticals Announce Late-Phase Development and Manufacturing Partnership for a First-In-Class Monoclonal Antibody
WuXi Biologics and Harbour BioMed Announce Strategic Development and Manufacturing Partnership